Abstract

Polyurethanes (PU) have recently emerged as promising biomaterials for tissue adhesive applications. Compared to other tissue adhesives, they offer substantial advantages such as the possibility to tailor adhesive strengths and curing times, for instance. All these properties are directly affected by the composition and final architecture. In this work, biobased two-components PU sealants were prepared, based on (i) an isocyanate-terminated prepolymer and (ii) a chain extender. Here, an exhaustive evaluation of the oligoester-diols and chain extenders influence on the sealants properties has been performed. In order to bring controlled variations on the final macromolecular architectures, three different prepolymers were prepared: two are based on poly(3-hydroxybutyrate) diol oligomers and another one on poly(lactic acid) diol oligomers, with a 50/50 isocyanate molar ratio of hexamethylene diisocyanate and biobased dimeryl diisocyanate. To study the chain extenders influence, five different aliphatic and linear bifunctional molecules were assessed, with varying length and functional groups reactivity. Ultimately, PUs obtained after the two-component systems curing were also fully characterized. They exhibited an overall good biocompatibility around 80%, with limited cytotoxicity. A wide range of physico-chemical and mechanical properties were also obtained, evidencing the importance of the macromolecular architecture on the systems final properties.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.